Shanthala FMCG Products Reports Audit-Linked Management Changes

Shanthala FMCG Products Limited reported audit-linked management changes after its board removed CFO Yogish Mallya and appointed Ratnakar Rai on October 31, 2026, following forensic audit issues. The developments came after a delayed FY26 audit filing, while Q2 FY26 net profit had risen 453.8% year on year.

What management changes did Shanthala FMCG Products report?

Shanthala FMCG Products said its board removed Yogish Mallya as chief financial officer and appointed Ratnakar Rai at its October 31, 2026 meeting. The board also approved the company's FY26 audited results, according to the stated outcome of the meeting.

The company linked the management action to forensic audit issues. The available disclosure does not state the detailed findings of the forensic review, the scope of the issues identified, or their financial effect. Shanthala FMCG had earlier identified Yogish Mallya as director of finance and CFO, with his appointment shown from May 8, 2023.

Why were Shanthala FMCG Products' FY26 results delayed?

Shanthala FMCG Products notified the NSE on May 30, 2026 that it would delay the submission of standalone and consolidated audited financial results for the year ended March 31, 2026. The company cited pending clarifications sought by its statutory auditors from management and the CFO, with the accounts yet to be finalised at that stage.

The notice was made under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. A delay in audited results is relevant for shareholders because audited statements provide the final reported basis for assessing annual revenue, profit, cash flow, assets and liabilities. No revised date was stated in the delay disclosure provided.

How did the forensic audit process unfold?

Shanthala FMCG Products' board met on June 7, 2026 to approve the appointment of a forensic auditor and address the need for independent verification. The company has also informed the exchange about a change in forensic auditor, though the supplied disclosures do not identify the auditor or specify the reason for the change.

The sequence places the forensic review after the May disclosure on the incomplete FY26 audit and before the October board outcome. The information available establishes that the company sought independent verification and subsequently changed its CFO, but it does not establish whether any past financial statements will be restated.

What do the disclosures mean for investors and operations?

The disclosures make audit completion, forensic review updates and the clarity of the FY26 audited statements central issues for investors. The company has reported strong Q2 FY26 percentage growth, with revenue up 37.9% and net profit up 453.8% from the corresponding quarter a year earlier. However, no absolute quarterly revenue or profit figures were supplied with this information.

Cash-flow data also shows uneven conversion of operating profit into cash across years. The CFO-before-tax to operating-profit ratio was 15% in March 2025 and was shown as negative 0% in March 2026, compared with 326% in March 2023 and negative 15,360% in March 2024. These figures should be read alongside the final audited accounts and accompanying disclosures.

What other corporate developments have been disclosed?

Shanthala FMCG was converted into a public limited company on July 10, 2023. During the year, it also incorporated a wholly owned subsidiary, although the supplied extract does not provide the subsidiary's name or business activity.

The company has proposed changing Bantwal Shobitha Malya's designation from executive director to managing director for a five-year term starting September 26, 2025 and ending September 25, 2030, subject to member approval at the annual general meeting. Separately, Shanthala FMCG stated on October 31 that related-party transaction disclosure was not applicable for FY2026.

Conclusion

Shanthala FMCG's audit-related disclosures combine a delayed FY26 filing, a forensic auditor appointment and a subsequent CFO replacement. While the company reported sharp year-on-year growth in Q2 FY26, the available information does not provide the forensic audit findings or quantify any impact on the annual financial statements.

Investors should watch for the final FY26 standalone and consolidated audited results, further exchange disclosures on the forensic review, and the outcome of the proposed managing director designation. These disclosures will provide the next documented basis for assessing the company's financial reporting and governance position.